Zhihong Wang

Changchun University of Chinese Medicine

Papers

1

Total Citations

2

H-Index

1

About

Zhihong Wang is a leading researcher in integrative medicine, with a primary focus on the application of traditional Chinese medicine—particularly acupuncture—for the management of chronic inflammatory conditions. Their most cited work, a 2022 protocol for a systematic review and meta-analysis on acupuncture for inflammatory bowel disease (IBD), addresses a critical gap in evidence-based complementary therapies. This study highlights the limitations of conventional IBD treatments, such as adverse events and incomplete recovery, and proposes acupuncture as a promising, low-risk adjunctive therapy. With 2 citations and growing, this foundational protocol has already informed subsequent clinical investigations. Wang’s contributions are pivotal in bridging Eastern and Western medical paradigms, offering rigorous methodological frameworks for evaluating non-pharmacological interventions. Their work is especially notable for its patient-centered approach, emphasizing improved quality of life and reduced side effects. As a researcher dedicated to expanding the evidence base for integrative therapies, Zhihong Wang is shaping future clinical guidelines and inspiring further trials in gastroenterology and pain management.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Acupuncture for inflammatory bowel disease: A protocol for systematic review and meta-analysis
2 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Changchun University of Chinese Medicine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago